Cellular Biomedicine Group to take company private in merger agreement

Cellular Biomedicine Group Inc., a biopharmaceutical firm in Gaithersburg engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced Wednesday it has signed a definitive merger agreement to be acquired by a newly-formed entity consisting of the CEO and certain other members of CBMG management. Company CEO Bizuo “Tony” ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *